Implants Make Top 10

Business 2.0 calls implantable devices one of “The jordan pas cher Top-10 Products, Ideas and Trends” destined to shape the future. While pharma’s busy trying to cope with its dry-pipeline problem, “…companies like Boston Scientific, Medtronic, and an array of startups are readying dozens of devices that reprogram the brain and other parts of the nervous system to tackle everything from migraines to severe depression.” 2.0 says there are roughly 20 devices up for FDA approval between mid-March and June; a similar-sized batch is expected for the second half of 2007. Bijan Salehizadeh of Highland Capital tells 2.0, “The potential for devices is astonishing. It’s as vast as the scope of disease itself.” The article includes a cool gallery of current and forthcoming devices.

The comments are closed.